Navigation Links
Study Findings Show Infection Control Intervention Helps Keep Kids in School
Date:6/2/2008

Disinfecting and using hand sanitizers helped reduce absenteeism rates in elementary schools

BOSTON, June 2 /PRNewswire-USNewswire/ -- A study from researchers at Children's Hospital Boston published in Pediatrics found that a simple infection control intervention in elementary schools -- disinfecting frequently-touched surfaces and using alcohol-based hand sanitizers -- helped reduce illness-related student absenteeism.

Illnesses caused by bacteria and viruses account for millions of lost school days each year.(1) According to Thomas Sandora, MD, MPH, a pediatric infectious diseases specialist at Children's Hospital Boston, "The best ways to avoid common infections are cleaning your hands and preventing exposure to the germs that cause these illnesses. Our research indicates that elementary schools should consider a few simple infection control practices to help keep students healthier."

The study, led by Dr. Sandora, was a randomized, controlled trial involving 285 third-, fourth-, and fifth-grade students in an elementary school system in Avon, Ohio. Teachers in intervention classrooms used disinfecting wipes on student desks, and students used hand sanitizer in the classroom at key points throughout the school day. Control classrooms followed usual hand washing and cleaning procedures.

Over eight weeks, researchers tracked the frequency of absences and the reasons for missing school. Study investigators also tested several classroom surfaces for total bacterial counts and for the presence of several common viruses.

Researchers found absenteeism rates for gastrointestinal illnesses were nine percent lower in classrooms that followed the infection control regimen of disinfecting surfaces and using alcohol-based hand sanitizers. The absenteeism rate for respiratory illness was not affected by this intervention.

Gastrointestinal illnesses are extremely common for school-age children, and children can be at risk fo
'/>"/>

SOURCE Children's Hospital Boston
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
4. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
5. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
6. Potential Safety Issue Identified in Ongoing Phase 2 Clinical Study of HCV-796
7. Study Suggests High-Dose Fish Oil May Significantly Improve Behavior in Children with ADHD
8. MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study
9. Video: Landmark Study in The Lancet: Patients Treated With Betaseron(R) After First MS Attack Experienced Significant Delay in MS Progression
10. MacroGenics Begins Global Phase 2/3 Protege Study in Recent-onset Type 1 Diabetes Mellitus
11. Sarasotas Roskamp Institute Releases Study Defining a Mechanism for Development of Obesity and the Metabolic Syndrome, Forerunners of Type 2 Diabetes

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...swire-FirstCall/--Pharmasset,Inc.(Nasdaq: VRUS ),a...vering,developingandcommercializingnoveldrugstotre...scalyearendedSeptember30,2009.AtSeptember30,2009Ph...hortterminvestments. ,, PipelineUpdateand2009H..., InlateNovember2009,anindependentDataMonitorin...
(Date:11/25/2009)...,Nov.25/PRNewswire/-- FromNovember16-18,Phonak,the...esentedthesecondeditionoftheHearingCareforAdultsCo...tion.Theconferencebroughttogetherleadingexpertsina...inicianswhoworkeverydaywitholderpeoplewithhearingl...latestresearchandtrendsinhearingcareforolderpeople...
(Date:11/25/2009)...ewswire/--TheFDAgrantedtraditionalapprovalforINTEL...setranscriptaseinhibitor(NNRTI).INTELENCEistheonly...encedadultswhoareexperiencingvirologicfailurewithH...l(ARV)agents.Thetraditionalapprovalisbasedon48-wee...TELENCEiscurrentlymarketedintheU.S.byTibotecTherap...
Breaking Medicine Technology:Pharmasset Reports Fiscal Year End 2009 Financial Results 2Pharmasset Reports Fiscal Year End 2009 Financial Results 3Pharmasset Reports Fiscal Year End 2009 Financial Results 4Pharmasset Reports Fiscal Year End 2009 Financial Results 5Pharmasset Reports Fiscal Year End 2009 Financial Results 6Pharmasset Reports Fiscal Year End 2009 Financial Results 7Pharmasset Reports Fiscal Year End 2009 Financial Results 8Phonak Successfully Hosts Hearing Care for Adults 2009 Conference 2Phonak Successfully Hosts Hearing Care for Adults 2009 Conference 3U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 2U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 3U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 4Netech Corporation Announces the Release of IPA 2000 Infusion Pump Analyzer for Fast and Accurate Testing of All Infusion Pumps 14891 1Netech Corporation Announces the Release of IPA 2000 Infusion Pump Analyzer for Fast and Accurate Testing of All Infusion Pumps 14891 2Bay Area Plastic Surgeon Reaches Out to Patients with New State of the Art Website 61595 1Bay Area Plastic Surgeon Reaches Out to Patients with New State of the Art Website 61595 2Bay Area Plastic Surgeon Reaches Out to Patients with New State of the Art Website 61595 3Bull 26apos 3Bs Eye 3A AHF 26apos 3Bs 26amp 3B 238220 3BNo Judgemental Bullsh t 26amp 3B 238221 3B HIV Testing Campaign Hits the Mark 61590 1Bull 26apos 3Bs Eye 3A AHF 26apos 3Bs 26amp 3B 238220 3BNo Judgemental Bullsh t 26amp 3B 238221 3B HIV Testing Campaign Hits the Mark 61590 2Bull 26apos 3Bs Eye 3A AHF 26apos 3Bs 26amp 3B 238220 3BNo Judgemental Bullsh t 26amp 3B 238221 3B HIV Testing Campaign Hits the Mark 61590 3
...one Systems Incorporated,(Nasdaq: IMCL ) and Bris...nced,that the U.S. Food and Drug Administration (F...ximab) product labeling to include overall surviva...r inhibitor,(EGFR)-expressing metastatic colorecta...notecan- and oxaliplatin-based regimens. The appr...
...cond Cerimon Product Candidate to Enter Clinical ...SAN FRANCISCO, Oct. 2 Cerimon Pharmaceuticals,Inc...ical study of a novel,diclofenac sodium patch, the...e safety, tolerability, and systemic pharmacokinet...odium, a non-steroidal anti-inflammatory,drug (NSA...
Other Medicine Technology:Survival Data in FDA Approval for ERBITUX(R) (Cetuximab) Supports use as a Single Agent in Patients with Advanced Colorectal Cancer 2Survival Data in FDA Approval for ERBITUX(R) (Cetuximab) Supports use as a Single Agent in Patients with Advanced Colorectal Cancer 3Survival Data in FDA Approval for ERBITUX(R) (Cetuximab) Supports use as a Single Agent in Patients with Advanced Colorectal Cancer 4Survival Data in FDA Approval for ERBITUX(R) (Cetuximab) Supports use as a Single Agent in Patients with Advanced Colorectal Cancer 5Survival Data in FDA Approval for ERBITUX(R) (Cetuximab) Supports use as a Single Agent in Patients with Advanced Colorectal Cancer 6Survival Data in FDA Approval for ERBITUX(R) (Cetuximab) Supports use as a Single Agent in Patients with Advanced Colorectal Cancer 7Cerimon Pharmaceuticals Initiates Phase I Clinical Study of Topical Diclofenac Sodium Patch 2Cerimon Pharmaceuticals Initiates Phase I Clinical Study of Topical Diclofenac Sodium Patch 3
(Date:11/25/2009)...s,andPressJoinEfforttoEducate ,, MEMPHIS,Tenn....nalBipolarFoundationandtheMedicAlertFoundationrece...ram,whichisnowbeingwidelyacceptedasapreventiveheal...ipolarFoundationreceivedaproclamationofendorsement...ouisianaMitchLandrieu.TheNationalBipolarFoundation...
(Date:11/25/2009)...istically significant survival benefit from adjuva...r (ER)-positive tumors had high levels of phosphor...P), according to a brief communication published o...Cancer Institute . , Approximately 50% of breast...l studies have shown that ER-alpha S118-P is requi...
(Date:11/25/2009)...s simple question has been the focus of intense re...dulates High Blood Pressure in Mice & Men, Does s...on has been the focus of intense research for many...stablished a link between a novel gene, phosducin,... as well as humans. The studies were directed by s...
(Date:11/25/2009)... arthritis, could help newly diagnosed diabetics, ...thDay News) -- A drug commonly used to treat non-H...o shows some promise in helping patients newly dia...mab (Rituxan), helped patients keep producing some... destroyed some of their pancreatic beta cells, wh...
(Date:11/25/2009)...o overlook needed care, study finds , , ...depression can worsen her child,s asthma, U.S. res... 262 black mothers and their children found that c... had more frequent asthma symptoms, while children...s frequent asthma symptoms. , The Johns Hopkins...
Breaking Medicine News(10 mins):Health News:First Time-Door is Open for Family Discussion of Bipolar Disorder 2Health News:First Time-Door is Open for Family Discussion of Bipolar Disorder 3Health News:New stress-related gene modulates high blood pressure in mice and men 2Health News:Type 1 Diabetes May Have a New Foe 2Health News:Type 1 Diabetes May Have a New Foe 3Health News:Mom's Depression May Worsen Child's Asthma 2
...arry Minnix, President & CEO, American Association...ation of the Medicare Therapy,Caps Exceptions Proc...,from Larry Minnix, President & CEO, American Asso...in having their physical and,occupational therapy ...
... The American Medical,Association (AMA) Foundation...ysician association, recently named several new bo...ers:, -- Jean Howard, Traverse City, MI, Preside...aynard, M.D., Evansville, IN, Secretary, New Mem...
...l sunscreen available at retailers nationwide and ... , ORLANDO, Fla., July 2 Caribbean Solutions,( h...een, Caribbean Sol,SolGuard SPF 25 and Kids Kare 2...ttp://www.newscom.com/cgi-bin/prnh/20080702/LAW520...
... only to childbirth as most common reason for hosp..., July 2 (HealthDay News) -- In 2006, more than 1....opulation of Dallas -- were hospitalized for pneum...mission to hospital, and treating these lung infec...
...Technologies from Los Alamos National Laboratory ... Airplanes, Cars Go On a Nanotechnology ...fics (Pink Sheets: MHTX) announced today that it h...enator,Jeff Bingaman said, "I believe the merger o...
...(July 2, 2008) - Measuring calcium deposits in the...isk in American adults, even when they are elderly...ssue of Journal of the American College of Cardio...l Center (LA BioMed), said previous studies had fo...
Other Medicine News:Health News:AAHSA Statement: Therapy Caps Ration Care 2Health News:Caribbean Sol Biodegradable Sunscreen Gets Strong Safety Rating From Environmental Working Group 2Health News:Manhattan Scientifics Acquires Metallicum, Inc. 2Health News:Manhattan Scientifics Acquires Metallicum, Inc. 3Health News:Manhattan Scientifics Acquires Metallicum, Inc. 4Health News:New study finds coronary arterial calcium scans help detect overall death risk in the elderly 2
Liquichek D-dimer Control
... use in assessing compliance with specimen handlin...f custody, for Federal Workplace Drug Testing Prog...ealth Services Administration (SAMHSA), Health and... agencies. These samples are confirmed negative fo...
Liquichek Reticulocyte Stain
Seroconversion and Antigen Panel Chart
Medicine Products: